DataMeds AI Provides Update on Corexa Health's Pharmacy Division

* GLP-1 agonist drugs now available * Integration of online store CorexaRx.com into Health Lives Here app now complete * Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available * Revenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health

TAMPA, FL / ACCESS Newswire / August 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today provided an update on the Company's pharmaceuticals-focused subsidiary Corexa Health's pharmacy division Corexa Pharmacy. Corexa Pharmacy recently achieved several qualitative and quantitative milestones that position it to be the centerpiece of Company growth in the 2(nd) half of 2026.